- Home
- NCTY vs ATRA Comparison
NCTY vs ATRA Comparison
Compare NCTY & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NCTY
- ATRA
- Stock Information
- Founded
- NCTY 1999
- ATRA 2012
- Country
- NCTY China
- ATRA United States
- Employees
- NCTY N/A
- ATRA N/A
- Industry
- NCTY Business Services
- ATRA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- NCTY Consumer Discretionary
- ATRA Health Care
- Exchange
- NCTY Nasdaq
- ATRA Nasdaq
- Market Cap
- NCTY 121.2M
- ATRA 97.0M
- IPO Year
- NCTY 2004
- ATRA 2014
- Fundamental
- Price
- NCTY $9.99
- ATRA $15.21
- Analyst Decision
- NCTY
- ATRA Strong Buy
- Analyst Count
- NCTY 0
- ATRA 3
- Target Price
- NCTY N/A
- ATRA $21.00
- AVG Volume (30 Days)
- NCTY 124.6K
- ATRA 54.6K
- Earning Date
- NCTY 01-01-0001
- ATRA 11-06-2025
- Dividend Yield
- NCTY N/A
- ATRA N/A
- EPS Growth
- NCTY N/A
- ATRA N/A
- EPS
- NCTY N/A
- ATRA 0.56
- Revenue
- NCTY $15,305,175.00
- ATRA $188,667,000.00
- Revenue This Year
- NCTY N/A
- ATRA N/A
- Revenue Next Year
- NCTY N/A
- ATRA N/A
- P/E Ratio
- NCTY N/A
- ATRA $27.00
- Revenue Growth
- NCTY N/A
- ATRA 202.41
- 52 Week Low
- NCTY $7.07
- ATRA $5.01
- 52 Week High
- NCTY $20.59
- ATRA $18.71
- Technical
- Relative Strength Index (RSI)
- NCTY 53.14
- ATRA 55.36
- Support Level
- NCTY $8.62
- ATRA $14.14
- Resistance Level
- NCTY $10.00
- ATRA $16.15
- Average True Range (ATR)
- NCTY 0.74
- ATRA 1.06
- MACD
- NCTY 0.02
- ATRA -0.11
- Stochastic Oscillator
- NCTY 50.51
- ATRA 44.28
About NCTY The9 Limited American Depository Shares
The9 Ltd operates a cryptocurrency mining business. It provides computing power, or hash rate, to a Bitcoin mining pool and is entitled to receive a fractional share of Bitcoin award from the Bitcoin mining pool in return. The company generates its revenues from customers in Greater China, Asia/Eastern Europe, and North America. Its segments are: Crypto mining business, and Other, out of which Crypto mining business derives maximum revenue.
About ATRA Atara Biotherapeutics Inc.
Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA188, and ATA3219 (CAR T Platform).